BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15972217)

  • 1. The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.
    Okuda Y; Okuda M; Apatoff BR; Posnett DN
    J Neurol Sci; 2005 Aug; 235(1-2):11-7. PubMed ID: 15972217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
    Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):249-52. PubMed ID: 7697540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
    Haegele KF; Stueckle CA; Malin JP; Sindern E
    J Neuroimmunol; 2007 Feb; 183(1-2):168-74. PubMed ID: 17084910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.
    Sweeney ME; Slusser JG; Lynch SG; Benedict SH; Garcia SL; Rues L; LeVine SM
    Int Immunopharmacol; 2011 Nov; 11(11):1796-801. PubMed ID: 21807124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+)CD45RO(+)CD49d(high) cells are involved in the pathogenesis of relapsing-remitting multiple sclerosis.
    Barrau MA; Montalban X; Sáez-Torres I; Brieva L; Barberà N; Martínez-Cáceres EM
    J Neuroimmunol; 2000 Nov; 111(1-2):215-23. PubMed ID: 11063841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a.
    Avolio C; Ruggieri M; Cafforio P; Giuliani F; Silvestris F; Dammacco F; Livrea P; Trojano M
    J Neurol Sci; 2001 May; 186(1-2):65-73. PubMed ID: 11412874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.
    Vrethem M; Dahle C; Ekerfelt C; Forsberg P; Danielsson O; Ernerudh J
    Acta Neurol Scand; 1998 Apr; 97(4):215-20. PubMed ID: 9576634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.
    Matsui M; Araya S; Wang HY; Matsushima K; Saida T
    J Neurol; 2005 Aug; 252(8):908-15. PubMed ID: 15772738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Plantone D; Patanella AK; Tonali PA; Batocchi AP
    Hum Immunol; 2010 May; 71(5):437-41. PubMed ID: 20138197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
    Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
    Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of naive/memory (CD45RA/CD45RO) markers by peripheral blood CD4+ and CD8 + T cells in children with asthma.
    Machura E; Mazur B; Pieniazek W; Karczewska K
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):55-62. PubMed ID: 18250971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
    Jilek S; Schluep M; Rossetti AO; Guignard L; Le Goff G; Pantaleo G; Du Pasquier RA
    Clin Immunol; 2007 Apr; 123(1):105-13. PubMed ID: 17188575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood T lymphocyte subsets in children with congenital asplenia.
    Motkowski R; Michalkiewicz J; Mikoluc B; Smolka-Afifi D; Pietrucha B; Kubiszewska I; Piotrowska-Jastrzebska J; Bernatowska E
    Hum Immunol; 2012 Nov; 73(11):1091-7. PubMed ID: 22902394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.
    Hueman MT; Stojadinovic A; Storrer CE; Dehqanzada ZA; Gurney JM; Shriver CD; Ponniah S; Peoples GE
    Cancer Immunol Immunother; 2007 Feb; 56(2):135-46. PubMed ID: 16783576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
    Hintzen RQ; Pot K; Paty D; Oger J
    Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.
    Mikulkova Z; Praksova P; Stourac P; Bednarik J; Strajtova L; Pacasova R; Belobradkova J; Dite P; Michalek J
    Cell Immunol; 2010; 262(2):75-9. PubMed ID: 20219185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
    Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
    Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.